Flagship explainer
How VERTEX PHARMACEUTICALS INC / MA makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $12.0B | 100% |
| |
| Cost of revenue | $1.7B | 14% |
|
| $10.3B | 86% |
| |
| $4.2B | 35% |
| |
| Income before tax | $4.6B | 39% |
|
| Income tax | $690M | 6% |
|
| $4.0B | 33% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0000875320-26-000056